Sign In
Buy HROW
$33.32
+0.460 (+1.40%)
At Close: Jun 03, 2026
Harrow Health Announces Record First Quarter 2021 Financial Results
04:01pm, Tuesday, 11'th May 2021
Highlights for First Quarter 2021:
Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
05:00pm, Thursday, 15'th Apr 2021
NASHVILLE, Tenn., April 15, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the pricin
Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones
04:01pm, Wednesday, 14'th Apr 2021
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced it has commenced an underwritten registered public of
Harrow Health Announces Preliminary First Quarter 2021 Financial Results
04:00pm, Wednesday, 14'th Apr 2021
NASHVILLE, Tenn., April 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced certain preliminary unaudited financial results for t
Harrow Health, Inc.'s (HROW) CEO Mark Baum on Q4 2020 Results - Earnings Call Transcript
07:02pm, Monday, 08'th Mar 2021
Harrow Health, Inc.'s (HROW) CEO Mark Baum on Q4 2020 Results - Earnings Call Transcript
Harrow Health (HROW) Lags Q4 Earnings Estimates
06:59pm, Monday, 08'th Mar 2021
Harrow (HROW) delivered earnings and revenue surprises of -50.00% and 0.73%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results
04:01pm, Monday, 08'th Mar 2021
Company's Prior-Quarter Momentum Continues in Fourth Quarter Company's Prior-Quarter Momentum Continues in Fourth Quarter
Analysts Estimate Harrow Health (HROW) to Report a Decline in Earnings: What to Look Out for
05:26pm, Monday, 01'st Mar 2021
Harrow (HROW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021
09:00am, Thursday, 25'th Feb 2021
NASHVILLE, Tenn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), an ophthalmic-focused healthcare company, today announced that it will release its financial results for the fou
Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate
07:00am, Tuesday, 09'th Feb 2021
Company Expects to Begin Phase 2 Clinical Study in the Third Quarter of 2021 Company Expects to Begin Phase 2 Clinical Study in the Third Quarter of 2021
4 Top Medical Services Stocks to Beat COVID-19 Resurgence Crisis
12:47pm, Thursday, 17'th Dec 2020
The COVID-19 crisis has drastically transformed the fortune of the medical services industry. The industry has been witnessingsignificant demand for telemedicine-focused online medical services.
Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia Journal
07:30am, Thursday, 03'rd Dec 2020
NASHVILLE, Tenn., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that a study featuring its patented MKO Melt® formulation has been published in the American Ass
Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference
07:30am, Friday, 20'th Nov 2020
NASHVILLE, Tenn., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that Mark Baum, Harrow's Chief Executive Officer, and Andrew Boll, Harrow's Chief Financial Offic
Harrow Health, Inc. (HROW) CEO Mark Baum on Q3 2020 Results - Earnings Call Transcript
06:14pm, Monday, 09'th Nov 2020
Harrow Health, Inc. (HROW) CEO Mark Baum on Q3 2020 Results - Earnings Call Transcript
Harrow Health Publishes Third Quarter 2020 Letter to Stockholders
04:01pm, Monday, 09'th Nov 2020
NASHVILLE, Tenn., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the third quarter 2020. Please click here to review Harrow Health's Letter to S tockh
